Inmatics wins €40m in financing round

Inmatics Biotechnologies, a German bio-pharmaceutical company, has raised €40m in its second financing round, the largest private biotech financing round in Germany since 2001.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this